Human immunodeficiency virus: post-exposure prophylaxis. NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Human immunodeficiency virus: post-exposure prophylaxis.

Curr Opin Urol. 1999 Jan;9(1):51-5. Unique Identifier : AIDSLINE MED/20190271
Parschalk B; Pernerstorfer-Schon H; Department for Infectious Diseases, Internal Medicine I,; University Hospital of Vienna, Austria.

Abstract: Post-exposure prevention is a combined modality approach to reducing HIV transmission. The recommendations are based on the risk of local prevalence and on the likelihood of transmission. In the light of the severe consequences of HIV infection, post-exposure prophylaxis after occupational exposure should be recommended. The medication, consisting of a potent antiretroviral combination (two nucleoside analogues and one reverse transcriptase inhibitor), should be available within two hours.
Keywords: JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL Anti-HIV Agents/*THERAPEUTIC USE Decision Support Techniques Human HIV Infections/*PREVENTION & CONTROL/TRANSMISSION Occupational Exposure/PREVENTION & CONTROL Sex Behavior Time Factors

KWDjournalarticlereviewreview,tutorialanti-hivagents/KWDtherapeuticusedecisionsupporttechniqueshumanhivinfections/KWDprevention&control/transmissionoccupationalexposure/prevention&controlsexbehaviortimefactors
000630
A0061948

Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .